Ascendis Pharma AS (ASND) — Cash Flow Quality Index

Latest as of March 2026: -0.01x

Ascendis Pharma AS (ASND) has a Cash Flow Quality Index of -0.01x as of March 2026. Operating cash flow of $-7.85 Million is below net income of $639.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ASND long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.01x
Operating CF / Net Income

Operating Cash Flow

$-7.85 Million
USD

Net Income

$639.69 Million
USD

Data as of

Mar 2026
Most recent filing

Ascendis Pharma AS Cash Flow Quality Index (2012–2013)

Historical Cash Flow Quality Index for Ascendis Pharma AS across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ascendis Pharma AS tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Ascendis Pharma AS (2012–2013)

Year-by-year earnings quality comparison for Ascendis Pharma AS. For live market cap and the full company financial profile, see ASND market cap.

Year Quality Index Operating CF (USD) Net Income YoY Change
2013 1.55x $6.31 Million $4.08 Million ▲ +396.6%
2012 -0.52x $-652.00K $1.25 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.